Lloyd D Frink sold $476k of ZG
Co -Exec. Chairman & President at ZILLOW GROUP, INC.. 5,832 shares at an average of $81.70, traded Sep 22, 2025, filed Sep 24, 2025.
Score components
- +20RolePresident
- +18Trade size$476k at market
- 0Share of holdings soldSold 0.3% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-25-042657, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 22, 2025 | MOption exercise Class C Capital Stock10b5-1 | +3,333 | $22.41 | $75k | 2,236,522 | Sep 24, 2025 |
| Sep 22, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -1,315 | $81.27 | $107k | 2,235,207 | Sep 24, 2025 |
| Sep 22, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -515 | $82.39 | $42k | 2,234,692 | Sep 24, 2025 |
| Sep 22, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -1,393 | $83.88 | $117k | 2,233,299 | Sep 24, 2025 |
| Sep 22, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -110 | $84.68 | $9,315 | 2,233,189 | Sep 24, 2025 |
| Sep 23, 2025 | MOption exercise Class C Capital Stock10b5-1 | +1,712 | $22.41 | $38k | 2,234,901 | Sep 24, 2025 |
| Sep 23, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -1,448 | $80.41 | $116k | 2,233,453 | Sep 24, 2025 |
| Sep 23, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -264 | $81.24 | $21k | 2,233,189 | Sep 24, 2025 |
| Sep 24, 2025 | MOption exercise Class C Capital Stock10b5-1 | +787 | $22.41 | $18k | 2,233,976 | Sep 24, 2025 |
| Sep 24, 2025 | SOpen-market sale Class C Capital Stock10b5-1 | -787 | $80.19 | $63k | 2,233,189 | Sep 24, 2025 |
| Sep 22, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -3,333 | $0.00 | $0 | 86,667 | Sep 24, 2025 |
| Sep 23, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -1,712 | $0.00 | $0 | 84,955 | Sep 24, 2025 |
| Sep 24, 2025 | MOption exercise Stock Option (right to buy)derivative10b5-1 | -787 | $0.00 | $0 | 84,168 | Sep 24, 2025 |
Related signals
Other insiders at ZILLOW GROUP, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 8Weak | ZILLOW GROUP, INC. | Erik C Blachford director | $28k 792 shares | -2% | |
| 19Weak | ZILLOW GROUP, INC. | Thielke Claire Cormier director | $42k 1,187 shares | -33% | |
| 1Weak | ZILLOW GROUP, INC. | Erik C Blachford director | $41k 966 shares | -3% | |
| 27Weak | ZGsell ZILLOW GROUP, INC. | David A. Beitel Chief Technology Officer | $175k 3,966 shares | -3% | |
| 18Weak | ZILLOW GROUP, INC. | Erik C Blachford director | $70k 965 shares | -3% | |
| 20Weak | ZILLOW GROUP, INC. | Thielke Claire Cormier director | $17k 241 shares | -50% | |
| 22Weak | ZILLOW GROUP, INC. | Bradley D. Owens General Counsel | $183k 2,722 shares | -7% | |
| 44Moderate | ZILLOW GROUP, INC. | David A. Beitel Chief Technology Officer | $277k 3,893 shares | -3% | |
| 47Moderate | ZILLOW GROUP, INC. | Jun Choo Chief Operating Officer | $223k 3,141 shares | -3% | |
| 46Moderate | ZILLOW GROUP, INC. | Jeremy Hofmann Chief Financial Officer | $936k 13,335 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.